Trials / Sponsors / Katy Peters, MD, PhD
Katy Peters, MD, PhD
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Low Grade Glioma of Brain | Phase 1 | 2025-07-15 |
| Completed | IDH1 Peptide Vaccine for Recurrent Grade II Glioma Brain Cancer, Brain Neoplasm, Primary, Brain Neoplasms, Recurrent | Phase 1 | 2016-01-28 |